Skip to content
Learn Motion
ExploreHow it worksMembership
Log in
Learn Motion

Insulin, Blood Sugar, and Diabetes: A Systematic Course

1Blood Glucose Homeostasis and the Endocrine Players2Insulin Secretion and the Insulin Receptor3Insulin Signaling and Cellular Glucose Uptake4Type 1 Diabetes: Autoimmune Beta-Cell Destruction5Type 2 Diabetes: Insulin Resistance and Beta-Cell Failure6Clinical Management: Connecting Mechanisms to Treatment
Clinical Management: Connecting Mechanisms to Treatment

Monitoring Control and the Basis of Complications

3 / 3
HbA1c measures the fraction of hemoglobin with glucose attached. Because red blood cells live about three months, it reflects average glucose over that period. It is the standard marker of long-term control, but it hides short-term swings, so it is used together with self-monitoring or continuous glucose monitoring. Those point measurements show post-meal spikes and overnight lows. The reason to control glucose is that chronic hyperglycemia damages small vessels and nerves, causing retinopathy, nephropathy, and neuropathy, and it accelerates large-vessel disease. Acute complications are different: hypoglycemia comes from treatment, especially insulin or sulfonylureas, while ketoacidosis comes from insulin deficiency in type 1 diabetes. Monitoring guides dose adjustment and catches these acute risks.
0:00 / 0:00

What HbA1c measures

HbA1c is the fraction of hemoglobin that has glucose attached. Because the attachment is irreversible and red blood cells live about three months, HbA1c integrates glucose exposure over that period. It does not show day-to-day variation, so a normal HbA1c can coexist with dangerous swings. This is why it is used alongside, not instead of, direct glucose measurement.

Why control matters

Persistent hyperglycemia injures small vessels and nerves, causing retinopathy, nephropathy, and neuropathy, and it accelerates atherosclerosis. These complications are the reason treatment targets exist. Acute problems such as hypoglycemia and ketoacidosis are tied to the treatment itself and to insulin deficiency, so monitoring must detect both the chronic trend and the acute event.

References

  1. [1]American Diabetes Association: A1C and eAGdiabetes.org
  2. [2]NIDDK: Diabetes Complicationsniddk.nih.gov
Previous3 / 3Complete

Learn Motion

Generate a course. Learn it properly.

Operated by Wuhan Daoyin Technology Co., Ltd.

Contact: [email protected]
Privacy PolicyTerms of Service

© 2026 Learn Motion